Goodwin Procter LLP advised AbCellera Biologics Inc. on the deal. AbCellera Biologics Inc. (Nasdaq: ABCL) announced its initial public offering of 27,772,500 common shares at a…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now